Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Hug

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Therapeutics|August 3, 2020
Safety, Pharmacokinetics, and Pharmacodynamics of the TLR4 Agonist GSK1795091 in Healthy Individuals: Results from a Randomized, Double-blind, Placebo-controlled, Ascending Dose StudyBruce A Hug, Christopher J Matheny, Olivia Burns, et al.
Cancer Research|May 23, 2002
Cooperative function of Aml1-ETO corepressor recruitment domains in the expansion of primary bone marrow cellsBruce A Hug, Samuel Y D Lee, Erron L Kinsler, et al.
Lancet (London, England)|March 3, 2015
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trialJoshua N Goldstein, Majed A Refaai, Truman J Milling, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Therapeutics|August 3, 2020
Safety, Pharmacokinetics, and Pharmacodynamics of the TLR4 Agonist GSK1795091 in Healthy Individuals: Results from a Randomized, Double-blind, Placebo-controlled, Ascending Dose StudyBruce A Hug, Christopher J Matheny, Olivia Burns, et al.
Cancer Research|May 23, 2002
Cooperative function of Aml1-ETO corepressor recruitment domains in the expansion of primary bone marrow cellsBruce A Hug, Samuel Y D Lee, Erron L Kinsler, et al.
Lancet (London, England)|March 3, 2015
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trialJoshua N Goldstein, Majed A Refaai, Truman J Milling, et al.
Pageof 2